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Background: Plasma blood glucose levels (BGLs) have been directly considered as independent prognostic factor regardless of diabetic status in 
patients with acute coronary syndromes. However, few data are available with regard to the association between BGLs and peri-procedural outcome 
in patients undergoing percutaneous coronary interventions (PCI). We aimed to investigate the relationship between glycemic status and procedural 
myocardial damage in non-diabetic patients treated with coronary stenting.
Methods: We prospectively enrolled 389 patients without history of diabetes who underwent PCI at our Institution. In all patients, blood glucose 
levels were measured before PCI and, according to these, pre-defined groups were considered: hypoglycemia < 80 mg/dl; euglycemia 81-109 mg/
dl; mild hyperglycemia 110-125 mg/dl; hyperglycemia > 126 mg/dl. Troponin I levels were recorded before and 8 and 24 hours after the procedure. 
Periprocedural myocardial infarction (MI) was defined as a post-procedural increase in creatine-kinase MB and/or troponin I > 3 times the upper 
normal limit (3.6 and 0.06 ng/ml, respectively).
Results: Hypoglycemia was significantly associated with an increased incidence of periprocedural myocardial infarction (63% vs 32% in euglycemia 
group, p = 0.006; p for trend 0.053). Any increase in troponin levels above the upper normal limit was also significantly more frequent in patients 
with pre-procedural blood glucose levels ≤ 80 mg/dl compared to the other groups.
Conclusions: This study demonstrated that a hypoglycemic status at the time of PCI is associated with increased incidence of peri-procedural 
myocardial damage also in patients without a previous diagnosis of diabetes mellitus. Pre-procedural hypoglycemia, by an enhanced release 
of inflammatory mediators and an increased platelet activation, may potentially amplify the pathologic mechanisms responsible for myocardial 
damage during coronary angioplasty. Glycemic monitoring may be indicated to improve in-hospital results in the setting of percutaneous coronary 
revascularization.
